[{"Assets_0_Q2_USD":131936152.0,"NetCashProvidedByUsedInOperatingActivities_1_Q2_USD":-30500000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-70779454.0,"NetIncomeLoss_1_Q2_USD":-25203780.0,"NetIncomeLoss_2_Q2_USD":-79464923.0,"StockholdersEquity_0_Q2_USD":-112707118.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":15894625.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":17530666.0,"Ticker":"AGEN","CIK":"1098972","name":"AGENUS INC","OfficialName":"Agenus Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"591453878.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180809"}]